FDA approves St. Jude Medical’s stroke prevention device

Saint Paul, Minn.-based St. Jude Medical earned Food and Drug Administration approval for the Amplatzer PFO Occluder.

Advertisement

The device, used to lower the risk of stroke, is intended for patients who already had one stroke caused by a blood clot passing through a hole in the heart and into the brain.

The device prevents a second stroke from occurring by closing up the hole in the patient’s heart. Clinicians insert the Amplatzer PFO Occluder through a catheter in a patient’s leg and into the patient’s heart.

More articles on supply chain:

FedEx subsidiary offers multi-tenant warehousing solution
5 latest FDA approvals
EpiPen price hikes cost DOD millions

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.